Reiter Sarah 4
4 · Arcadia Biosciences, Inc. · Filed Feb 4, 2020
Insider Transaction Report
Form 4
Reiter Sarah
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-03+50,000→ 121,705 totalExercise: $4.91Exp: 2030-02-03→ Common Stock (50,000 underlying) - Purchase
Common Stock
2020-02-03$1.72/sh+700$1,204→ 3,800 total
Footnotes (2)
- [F1]Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.
- [F2]The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024.